These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8033122

  • 21. Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors.
    Todo T, Rabkin SD, Martuza RL.
    Cancer Gene Ther; 2000 Jun; 7(6):939-46. PubMed ID: 10880026
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
    Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL.
    Nat Med; 1995 Sep; 1(9):938-43. PubMed ID: 7585221
    [Abstract] [Full Text] [Related]

  • 24. Herpes simplex virus-mediated gene delivery to the rodent visual system.
    Spencer B, Agarwala S, Miskulin M, Smith M, Brandt CR.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1392-401. PubMed ID: 10798655
    [Abstract] [Full Text] [Related]

  • 25. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S, Suzuki S, Hoshino A, Akimoto M, Shimada T.
    Cancer Gene Ther; 1997 May; 4(2):91-6. PubMed ID: 9080117
    [Abstract] [Full Text] [Related]

  • 26. Oncolytic recombinant herpes simplex virus for treatment of orthotopic liver tumors in nude mice.
    Chung YS, Miyatake S, Miyamoto A, Miyamoto Y, Dohi T, Tanigawa N.
    Int J Oncol; 2006 Apr; 28(4):793-8. PubMed ID: 16525626
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
    Toda M, Iizuka Y, Kawase T, Uyemura K, Kawakami Y.
    Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286
    [Abstract] [Full Text] [Related]

  • 34. Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
    Marconi P, Tamura M, Moriuchi S, Krisky DM, Niranjan A, Goins WF, Cohen JB, Glorioso JC.
    Mol Ther; 2000 Jan; 1(1):71-81. PubMed ID: 10933914
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.
    Kramm CM, Chase M, Herrlinger U, Jacobs A, Pechan PA, Rainov NG, Sena-Esteves M, Aghi M, Barnett FH, Chiocca EA, Breakefield XO.
    Hum Gene Ther; 1997 Nov 20; 8(17):2057-68. PubMed ID: 9414254
    [Abstract] [Full Text] [Related]

  • 36. Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector.
    Herrlinger U, Kramm CM, Aboody-Guterman KS, Silver JS, Ikeda K, Johnston KM, Pechan PA, Barth RF, Finkelstein D, Chiocca EA, Louis DN, Breakefield XO.
    Gene Ther; 1998 Jun 20; 5(6):809-19. PubMed ID: 9747461
    [Abstract] [Full Text] [Related]

  • 37. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM, Turunen M, Tyynelä K, Loimas S, Vainio P, Vanninen R, Vapalahti M, Bjerkvig R, Jänne J, Ylä-Herttuala S.
    Cancer Gene Ther; 2000 Mar 20; 7(3):413-21. PubMed ID: 10766347
    [Abstract] [Full Text] [Related]

  • 38. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.
    Cancer Gene Ther; 2006 Mar 20; 13(3):326-34. PubMed ID: 16138120
    [Abstract] [Full Text] [Related]

  • 39. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene].
    Quillien V, Heresbach Le Berre N, Dufour T, Denais A, Guegan Y, Ferry N, Bloin V.
    Bull Cancer; 1997 Nov 20; 84(11):1047-52. PubMed ID: 9536986
    [Abstract] [Full Text] [Related]

  • 40. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
    Ramesh R, Munshi A, Abboud CN, Marrogi AJ, Freeman SM.
    Cancer Gene Ther; 1996 Nov 20; 3(6):373-84. PubMed ID: 8988840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.